Asozit 40 mg (Capsule (Enteric Coated))
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | The white horse pharmaceuticals ltd |
Also available as |
Title
Asozit 40 mg Capsule
Categories
- Medicine
- Proton Pump Inhibitor
- Gastrointestinal Health
Description
Asozit 40 mg Capsule is a proton pump inhibitor (PPI) indicated for the relief of chronic heartburn, healing of erosive esophagitis, maintenance of healing of erosive esophagitis, eradication of Helicobacter pylori infection, treatment of Zollinger-Ellison Syndrome, acid-related dyspepsia, duodenal and gastric ulcers, and reduction of rebleeding of gastric or duodenal ulcers following therapeutic endoscopy.
DosageForm
Oral capsule
DosageStrength
40 mg
PackagingSize
10 capsules per pack
ColorOptions
- White
Dimensions
- Length: 2 cm
- Width: 2 cm
- Height: 1 cm
ActiveIngredient
Esomeprazole
InactiveIngredients
- Microcrystalline cellulose
- Crospovidone
- Magnesium stearate
- Talc
Pharmacology
- Suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase
- First single optical isomer of proton pump inhibitor
- Better acid control than racemic proton pump inhibitors
- Enteric-coated pellet formulation of esomeprazole magnesium
- Peak plasma levels occur at approximately 1.5 hours after oral administration
Absorption
Peak plasma levels (Cmax) occur at approximately 1.5 hours after oral administration
Distribution
- PlasmaProteinBinding: 97%
- ApparentVolumeOfDistribution: 16 L
Metabolism
Extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system
Excretion
- PlasmaEliminationHalfLife: Approximately 1-1.5 hours
- UrineExcretion: < 1%
- FaecesExcretion: Approximately 80%
- InactiveMetabolitesExcretion: Approximately 80% in urine, remainder in faeces
CombinationTherapy
- TripleTherapyDuration: 10 days
- Components:
- Esomeprazole 40 mg once daily
- Amoxicillin 1000 mg twice daily
- Clarithromycin 500 mg twice daily
ModeOfAction
Suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase
Indication
- Relief of chronic heartburn symptoms
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection in patients with duodenal ulcer disease
- Treatment of Zollinger-Ellison Syndrome
- Treatment of acid-related dyspepsia
- Treatment of duodenal and gastric ulcers
Administration
- Oral administration
- Swallowed whole
- One hour before a meal
Interaction
- Extensively metabolized in the liver by CYP2C19 and CYP3A4
- Unlikely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1, and 3A4
- Potential interference with CYP2C19, the major metabolizing enzyme
- No clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin, or amoxicillin
Contraindications
- Known hypersensitivity to any of the formulation
SideEffects
- Headache
- Diarrhoea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
PregnancyAndLactation
- StudiesInPregnantWomen: No adequate and well-controlled studies
- AnimalStudies: No teratogenic effects observed
- ExcretionInMilk: Not studied
- RecommendationForBreastfeeding: Discontinue breastfeeding if essential
PrecautionsAndWarnings
- Symptomatic response does not preclude the presence of gastric malignancy
- Tablets should be taken at least one hour before meals
- Patients with difficulty swallowing can open capsules and swallow pellets with applesauce
- Antacids may be used while taking Asozit
SpecialPopulations
- PediatricUse: Safety and effectiveness not established
- GeriatricUse: No overall differences in safety and efficacy observed between elderly and younger individuals
- HepaticInsufficiency: No dosage adjustment recommended for mild to moderate insufficiency
- RenalInsufficiency: Pharmacokinetics not expected to be altered in patients with renal impairment
OverdoseEffects
- Lethal to rats at 103 times the human dose on a body surface area basis
- Major signs of acute toxicity include reduced motor activity, changes in respiratory frequency, tremor, and clonic convulsions
- No specific antidote known, treatment should be symptomatic and supportive
StorageConditions
Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.
ChemicalStructure
- MolecularFormula: C17H19N3O3S
- Image: https://medex.com.bd/storage/res/g-res-433-esomeprazole-chemical-structure-Tj2Jfp1VmPkRjNXznKqC.svg
CommonlyAskedQuestions
- Questions:
- Question: What is Asozit 40 mg Capsule?
- Answer: A proton pump inhibitor used to treat GERD, ulcers, and other conditions related to excessive stomach acid.
- Question: What is Asozit 40 mg Capsule used for?
- Answer: Relief of heartburn, healing erosive esophagitis, and preventing its recurrence.
- Question: What are the side effects of Asozit 40 mg Capsule?
- Answer: Headache, diarrhea, nausea, flatulence, abdominal pain, constipation, dry mouth.
- Question: Can I take Asozit 40 mg Capsule if I am pregnant or breastfeeding?
- Answer: Talk to your doctor; no harmful effects reported in pregnant or breastfeeding individuals.
- Question: How long does it take for Asozit 40 mg Capsule to work?
- Answer: Usually starts to work within a few hours of taking it.
- Question: Quick Tips
- Answer:
- Well-tolerated and provides long-lasting relief
- Avoid eating late at night or before bedtime
- Consult doctor if you develop specific symptoms
- Potential for bone weakening with long-term use
Related Brands
- Esoz 40 mg (Capsule (Enteric Coated)) - astra-biopharmaceuticals-ltd
- Esoz 20 mg (Capsule (Enteric Coated)) - astra-biopharmaceuticals-ltd
- Esover 40 mg (Capsule (Enteric Coated)) - veritas-pharmaceuticals-ltd
- Prazia 20 mg (Capsule (Enteric Coated)) - amico-laboratories-ltd
- Prazia 40 mg (Capsule (Enteric Coated)) - amico-laboratories-ltd